Abstract:Background: Prolonged endoplasmic reticulum stress has been identified in various diseases. Inflammatory mediators, which have been shown to induce endoplasmic reticulum stress in several studies, have been suggested to serve as the important modulators in pain development. In this study, the authors hypothesized that the endoplasmic reticulum stress triggered by inflammatory mediators contributed to pain development. Methods: The authors used a male mouse model of bone cancer pain. The control mice were intrathecally injected with tumor necrosis factor-alpha (TNF-alpha) and lipopolysaccharide, the bone cancer pain mice were intrathecally injected with the endoplasmic reticulum stress inhibitors 4-PBA and GSK2606414. The nociceptive behaviors, endoplasmic reticulum stress markers, and inflammatory mediators were assessed. Results: Increased expression of the p-RNA-dependent protein kinase-like endoplasmic reticulum kinase and p-eukaryotic initiation factor 2 alpha were found in the spinal neurons during bone cancer pain, along with upregulation of inflammatory mediators (TNF-alpha, interleukin 1 beta, and interleukin 6). Intrathecal administration of TNF-alpha or lipopolysaccharide increased the expression of endoplasmic reticulum stress markers in control mice. Inhibition of endoplasmic reticulum stress by intrathecal administration of 4-PBA (baseline vs. 3 h: 0.34 +/- 0.16 g vs. 1.65 +/- 0.40 g in paw withdrawal mechanical threshold, 8.00 +/- 1.20 times per 2 min vs. 0.88 +/- 0.64 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) or GSK2606414 (baseline vs. 3 h: 0.37 +/- 0.08 g vs. 1.38 +/- 0.11 g in paw withdrawal mechanical threshold, 8.00 +/- 0.93 times per 2 min vs. 3.25 +/- 1.04 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) showed time- and dose-dependent antinociception. Meanwhile, decreased expression of inflammatory mediators (TNF-alpha, interleukin 1 beta, and interleukin 6), as well as decreased activation of astrocytes in the spinal cord, were found after 4-PBA or GSK2606414 treatment. Conclusions: Inhibition of inflammatory mediator-triggered endoplasmic reticulum stress in spinal neurons attenuates bone cancer pain via modulation of neuroinflammation, which suggests new approaches to pain relief.

Vinorelbine causes a neuropathic pain-like state in mice via STING and MNK1 signaling associated with type I interferon induction

Induction of antiviral interferon-stimulated genes by neuronal STING promotes the resolution of pain in mice

Activation of the STING Pathway Induces Peripheral Sensitization Via Neuroinflammation in a Rat Model of Bone Cancer Pain.

Nav1.8 in small dorsal root ganglion neurons contributes to vincristine-induced mechanical allodynia

STING/NF-κB/IL-6-Mediated Inflammation in Microglia Contributes to Spared Nerve Injury (SNI)-Induced Pain Initiation

Toll like receptor-4 is upregulated in mouse tail vein endothelial cells after Vinorelbine injection

Mechanism and effects of STING-IFN-I pathway on nociception: A narrative review.

Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through down-regulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones

TLR Signaling Adaptor Protein MyD88 in Primary Sensory Neurons Contributes to Persistent Inflammatory and Neuropathic Pain and Neuroinflammation

Microglial STING activation alleviates nerve injury-induced neuropathic pain in male but not female mice

STING recognition of viral dsDNA by nociceptors mediates pain in mice

Axotomy-Induced Up-Regulation of Tumor Necrosis Factor-Alpha in the Dorsal Root Ganglia

Spinal Macrophage Migration Inhibitory Factor is a Major Contributor to Rodent Neuropathic Pain-like Hypersensitivity

Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons

Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy

STING controls opioid-induced itch and chronic itch via spinal tank-binding kinase 1-dependent type I interferon response in mice

Stimulator of Interferon Genes Pathway Activation through the Controlled Release of STINGel Mediates Analgesia and Anti-Cancer Effects in Oral Squamous Cell Carcinoma

ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons

Endoplasmic Reticulum Stress Contributes to Nociception Via Neuroinflammation in a Murine Bone Cancer Pain Model.

Gastrodia elata Blume Polysaccharides Attenuate Vincristine-Evoked Neuropathic Pain through the Inhibition of Neuroinflammation

Interleukin 33-mediated inhibition of A-type K + channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice